Corvex Management’s Elevance Health ELV Stock Holding History

Corvex Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-25,000	Closed	-$5.68M	–	31
2020 Q1	$5.68M	Buy	+25,000	New	+$6.81M	0.44%	24

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Corvex Management's ELV Position: Q2 2020 in Review

Corvex Management sold out of Elevance Health (ELV) in Q2 2020, closing a stake of 25,000 shares — an estimated $5.68M sold.

Corvex Management first reported a position in ELV in Q1 2020 and held it in 1 quarter. The position peaked at $5.68M in Q1 2020. 1,106 funds tracked by Wall St. Rank hold ELV as of Q2 2020.

Corvex Management reported no remaining Elevance Health position as of Q2 2020 after selling out during the quarter.
Corvex Management sold 25,000 Elevance Health shares in Q2 2020, an estimated $5.68M.
Corvex Management first reported a position in Elevance Health in Q1 2020 and held it in 1 quarter.
Corvex Management's Elevance Health position peaked at $5.68M in Q1 2020.
1,106 funds tracked by Wall St. Rank held Elevance Health as of Q2 2020.

Based on Corvex Management's 13F filing for Q2 2020, filed 14 Aug 2020.